Please provide your email address to receive an email when new articles are posted on . An AI model accurately distinguished cardiac amyloidosis from other phenotypic mimics. The model also showed ...
An artificial intelligence (AI) model developed by Mayo Clinic and Ultromics, Ltd., an AI echocardiography company based in Oxford, England, is highly accurate in screening for cardiac amyloidosis, a ...
The bar for quality in cardiac amyloid radionuclide imaging is very high because the results from a single imaging scan can impact the diagnosis and treatment of patients with a devastating disease.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results